The actual question is what are the penalties in which these manufacturing businesses should face for improper labelling of the drug to the general public, specifically in the United States? Under the Federal Food, Drug, and Cosmetic Act, “The adulteration or misbranding of any food, drug, device or cosmetic in interstate commerce” [FD&C Act, sec. 301(b); 21 U.S.C. 331(b)] is violated due to misleading labelling of cosmetic products, withhold information about the highly toxic chemicals within the products. The penalty for violating the act can result, if deemed minor, a fine, and in cases where it is considered a felony, imprisonment. However, the ambiguity of the punishment by fine may not deter major manufacturing companies from continuing to mislabel their products. Are the companies purposely violating the act or is it an accident? Some of these questions need to be answered to understand the situation better.
For more information:
http://www.fda.gov/Cosmetics/GuidanceComplianceRegulatoryInformation/ucm074248.htm
https://blogs.ubc.ca/arailymakhylbekova/2012/09/12/toxic-nail-polish-ethical-issues-in-cosmetics/